shattucklabs.com (STTK) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Shattuck Labs, Inc. (STTK) is implementing robotic systems for accelerated bio-screening of anti-tumor proteins, eliminating routine tasks for scientists. This historical price chart with the 0.00 indicator confirms the company's market positions. American laboratories are creating unique protein fusions to combat cancer, leveraging financial stability. The development of bifunctional molecules for the therapy of autoimmune pathologies is supported by strategic capital and strict regulatory oversight.
shattucklabs.com - analytical breakdowns and key metrics (STTK)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
STTK - Net Profit|Future Profit Shattuck Labs, Inc.|STTK - Market Price to Net Income Ratio|Projected Price to Earnings Shattuck Labs|STTK - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio STTK|STTK - Operating profit EBITDA|Net earnings per share (EPS TTM) Shattuck Labs|STTK - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months shattucklabs.com|STTK - Earnings growth in current year|Expected earnings per share growth for next year Shattuck Labs, Inc.
Initial company analysis:STTK (Shattuck Therapeutics)
For Shattuck Labs, Inc. (STTK), the EV/EBITDA valuation multiple serves as a tool to monitor business value relative to operational cash flow amid high R&D expenditures for oncology drugs. The ratio of total enterprise value (market capitalization and debt) to earnings before interest, taxes, depreciation, and amortization allows investors to determine the extent of overpayment for the asset or identify an entry point during a market discount.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|PHVS: EV/EBITDA Multiple|AbCellera - Business Value to Operating Income Before Depreciation|TRML (Tourmaline Bio) - EV/EBITDA Multiple|EV/EBITDA Multiple Precigen Inc|Enterprise Value to EBITDA Ratio PHAR (Pharming)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ZBIO (zenasbio.com)|IMNM: Enterprise Value to EBITDA Ratio|GOSS - EV/EBITDA Multiple|KALV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Septerna Pharma|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|EV/EBITDA Multiple savarapharma.com|Enterprise Value to EBITDA Ratio RIGL (Rigel Pharmaceuticals, Inc.)|ANAB (AnaptysBio Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|enGene Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT Therapeutics - EV/EBITDA Multiple|JBIO - EV/EBITDA Multiple|ACRS: EV/EBITDA Multiple|KYTX (Kyverna Therapeutics Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|THTX (theratech.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|ZURA: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio atyrpharma.com|Enterprise Value to EBITDA Ratio ADAG|Ikena Oncology, Inc. (IMA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|Total Company Value to Operating Income Before Depreciation Ratio connectbiopharm.com|Immunic - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ATRA (Atara Biotherapeutics, Inc.)|IFRX: Enterprise Value to EBITDA Ratio|X4 Pharmaceuticals Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|barinthusbio.com - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple KZR|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GOVX (geovax.com)|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple XTL Bio|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|HCWB (hcwbiologics.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to EBITDA Ratio REVB|EV/EBITDA Multiple Indaptus Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Company Value to EBITDA|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
